Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma

Glioblastoma multiforme (GBM) is the most common and aggressive primary malignant tumor of the central nervous system. GBM has a very low 5-year survival rate and reaching merely a median of ~15 months even with aggressive treatments. PPARγ (Peroxisome proliferator- activated receptor gamma) agonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheu, Meei-Ling, Pan, Liang-Yi, Hu, Huai-Yun, Su, Hong-Lin, Sheehan, Jason, Tsou, Hsi-Kai, Pan, Hung-Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657575/
https://www.ncbi.nlm.nih.gov/pubmed/36362294
http://dx.doi.org/10.3390/ijms232113510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657575/
https://www.ncbi.nlm.nih.gov/pubmed/36362294
http://dx.doi.org/10.3390/ijms232113510

Ejemplares similares